Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination therapy consisting of artificial tears (lubricating eye drops) and corticosteroid eye drops. Artificial tears are over-the-counter or prescription lubricating solutions designed to mimic natural tears, providing moisture and relief from dry eye symptoms by maintaining the tear film on the ocular surface. They typically contain lubricants, electrolytes, oils, and sometimes preservatives[2]. Corticosteroid eye drops (such as prednisolone, loteprednol, dexamethasone) are prescription medications that reduce ocular inflammation by inhibiting inflammatory mediators in the eye[1][4][6]. This combination is used for managing moderate to severe dry eye disease or other inflammatory ocular conditions where both lubrication and anti-inflammatory action are needed. Artificial tears provide symptomatic relief while corticosteroids address underlying inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on artificial tears + corticosteroid drops.